Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Assets Average (2018 - 2025)

Neurogene's Assets Average history spans 6 years, with the latest figure at $288.2 million for Q4 2025.

  • For Q4 2025, Assets Average rose 15.32% year-over-year to $288.2 million; the TTM value through Dec 2025 reached $288.2 million, up 15.32%, while the annual FY2025 figure was $312.2 million, 11.83% up from the prior year.
  • Assets Average reached $288.2 million in Q4 2025 per NGNE's latest filing, down from $292.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $325.5 million in Q1 2025 to a low of $91.8 million in Q3 2023.
  • Average Assets Average over 3 years is $211.3 million, with a median of $198.3 million recorded in 2024.
  • Peak YoY movement for Assets Average: skyrocketed 94.93% in 2024, then increased 15.32% in 2025.
  • A 3-year view of Assets Average shows it stood at $156.1 million in 2023, then surged by 60.13% to $249.9 million in 2024, then increased by 15.32% to $288.2 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Assets Average are $288.2 million (Q4 2025), $292.6 million (Q3 2025), and $306.3 million (Q2 2025).